Ouyang Han, Shi Yong-bing, Su Nan, Li Ling-yun
Department of Nephrology, Second Affiliated Hospital, Soochow University, Suzhou 215004, China.
Zhonghua Yi Xue Za Zhi. 2013 Jan 8;93(2):99-103.
To examine the protein and mRNA levels of interleukin-9(IL-9) and the frequencies of CD4(+)IL-9(+)T-cells in peripheral blood of patients with systemic lupus erythematosus (SLE) and explore the roles of double positive T cells and IL-9 in the pathogenesis of SLE and the effects of glucocorticoid.
Twenty-eight hospitalized SLE patients were recruited and 12 healthy volunteers selected as normal controls. The mRNA levels of IL-9 in peripheral blood were measured by real time-polymerase chain reaction (RT-PCR), plasma protein of IL-9 by enzyme-linked immunosorbent assay (ELISA) and frequencies of CD4(+)IL-9(+)T-cells by flow cytometry. And the differences between two groups and the effects of glucocorticoid were analyzed.
(1) The mRNA levels of IL-9 were significantly elevated in SLE patients as compared with normal controls (P < 0.01). The serum levels of IL-9 were significantly higher in active and inactive SLE patients than those in healthy individuals (68 ± 11 vs 26 ± 6 ng/L, P < 0.01; 56 ± 14 vs 26 ± 6 ng/L, P < 0.05). The percentages of CD4(+)IL-9(+)T-cells increased in active SLE patients (1.96% ± 0.31%) versus inactive SLE patients (0.89% ± 0.13%, P < 0.01) and healthy controls (0.28% ± 0.05%, P < 0.001). And it was higher in inactive SLE patients than that in controls (P < 0.05). (2) The serum levels of IL-9 and the frequencies of CD4(+)IL-9(+)T-cells were positively correlated with SLE disease activity index (SLEDAI). (3) The frequencies of CD4(+)IL-9(+)T-cells and the serum levels of IL-9 in 8 untreated active SLE patients decreased at weeks 1, 2 and 3 after the therapy of methylprednisolone (0.8 mg×kg(-1)×d(-1)) versus those at pre-treatment.
The abnormalities of IL-9 and CD4(+)IL-9(+)T-cells may play an important role in the pathogenesis of SLE. And the frequencies of CD4(+)IL-9(+)T-cells and the levels of IL-9 are evaluative parameters of SLE activity and severity.
检测系统性红斑狼疮(SLE)患者外周血中白细胞介素-9(IL-9)的蛋白和mRNA水平以及CD4(+)IL-9(+)T细胞频率,探讨双阳性T细胞和IL-9在SLE发病机制中的作用及糖皮质激素的影响。
招募28例住院SLE患者,并选取12名健康志愿者作为正常对照。采用实时聚合酶链反应(RT-PCR)检测外周血中IL-9的mRNA水平,酶联免疫吸附测定(ELISA)检测IL-9的血浆蛋白水平,流式细胞术检测CD4(+)IL-9(+)T细胞频率。分析两组之间的差异及糖皮质激素的影响。
(1)与正常对照相比,SLE患者IL-9的mRNA水平显著升高(P < 0.01)。活动期和非活动期SLE患者血清IL-9水平均显著高于健康个体(68±11 vs 26±6 ng/L,P < 0.01;56±14 vs 26±6 ng/L,P < 0.05)。活动期SLE患者CD4(+)IL-9(+)T细胞百分比高于非活动期SLE患者(1.96%±0.31% vs 0.89%±0.13%,P < 0.01)和健康对照(0.28%±0.05%,P < 0.001)。且非活动期SLE患者高于对照(P < 0.05)。(2)血清IL-9水平和CD4(+)IL-9(+)T细胞频率与SLE疾病活动指数(SLEDAI)呈正相关。(3)8例未经治疗的活动期SLE患者在甲泼尼龙(0.8 mg×kg(-1)×d(-1))治疗1、2和3周后,CD4(+)IL-9(+)T细胞频率和血清IL-9水平较治疗前降低。
IL-9和CD4(+)IL-9(+)T细胞异常可能在SLE发病机制中起重要作用。CD4(+)IL-9(+)T细胞频率和IL-9水平是SLE活动度和严重程度的评估指标。